Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1920 ARTÍCULOS , VIENDO DEL 1456 AL 1470

The Great Debate in Diagnosing Alzheimer Disease: More Than Just a β Test

Villain N, Paretsky MS.

Neurology. 2024 Sep 10;103(5):e209836. doi: 10.1212/WNL.0000000000209836. Epub 2024 Aug 21.

Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer's disease pathology in the eye clinic

Bader I, Groot C, Tan HS, Milongo JA, Haan JD, Verberk IMW, Yong K, Orellina J, Campbell S, Wilson D, van Harten AC, Kok PHB, van der Flier WM, Pijnenburg YAL, Barkhof F, van de Giessen E, Teunissen CE, Bouwman FH, Ossenkoppele R.

Alzheimers Res Ther. 2024 Aug 21;16(1):190. doi: 10.1186/s13195-024-01545-1.

Understanding the impact of slowing disease progression for individuals with biomarker-confirmed early symptomatic Alzheimer's disease

Desai U, Gomes DA, Chandler J, Ye W, Daly M, Kirson N, Dennehy EB.

Curr Med Res Opin. 2024 Oct;40(10):1719-1725. doi: 10.1080/03007995.2024.2394602. Epub 2024 Sep 1.

Building expert consensus regarding sharing of individual research results in Alzheimer's disease research: a Delphi study protocol

Sankary LR, Rico V, Zelinsky M, Webster HS, Lerner AJ, Martinez K, Ford PJ, Tousi B, Leverenz J.

BMJ Open. 2024 Aug 24;14(8):e089242. doi: 10.1136/bmjopen-2024-089242.

Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA

Quaresima V, Pilotto A, Trasciatti C, Tolassi C, Parigi M, Bertoli D, Mordenti C, Galli A, Rizzardi A, Caratozzolo S, Benussi A, Ashton NJ, Blennow K, Zetterberg H, Giliani S, Brugnoni D, Padovani A.

Neurobiol Aging. 2024 Nov;143:30-40. doi: 10.1016/j.neurobiolaging.2024.08.007. Epub 2024 Aug 22.

Updates in Alzheimer's disease: from basic research to diagnosis and therapies

Liu E, Zhang Y, Wang JZ.

Transl Neurodegener. 2024 Sep 4;13(1):45. doi: 10.1186/s40035-024-00432-x.

Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: an update of the literature

Milos T, Vuic B, Balic N, Farkas V, Nedic Erjavec G, Svob Strac D, Nikolac Perkovic M, Pivac N.

Expert Rev Neurother. 2024 Nov;24(11):1063-1079. doi: 10.1080/14737175.2024.2400683. Epub 2024 Sep 4.

CSF and blood glial fibrillary acidic protein for the diagnosis of Alzheimer's disease: A systematic review and meta-analysis

Zou Y, Wang Y, Ma X, Mu D, Zhong J, Ma C, Mao C, Yu S, Gao J, Qiu L.

Ageing Res Rev. 2024 Nov;101:102485. doi: 10.1016/j.arr.2024.102485. Epub 2024 Sep 4.

Deciphering the role of miRNAs in Alzheimer's disease: Predictive targeting and pathway modulation - A systematic review

Sharma M, Pal P, Gupta SK.

Ageing Res Rev. 2024 Nov;101:102483. doi: 10.1016/j.arr.2024.102483. Epub 2024 Sep 3.

Breaking Barriers in Alzheimer's Disease: the Role of Advanced Drug Delivery Systems

Shekho D, Mishra R, Kamal R, Bhatia R, Awasthi A.

AAPS PharmSciTech. 2024 Sep 5;25(7):207. doi: 10.1208/s12249-024-02923-6.

Pathways to personalized medicine-Embracing heterogeneity for progress in clinical therapeutics research in Alzheimer's disease

Arnold SE, Hyman BT, Betensky RA, Dodge HH.

Alzheimers Dement. 2024 Oct;20(10):7384-7394. doi: 10.1002/alz.14063. Epub 2024 Sep 6.

[Blood Biomarkers for Alzheimer's Disease: Current Status and Prospects]

Ikeuchi T.

Brain Nerve. 2024 Sep;76(9):1045-1052. doi: 10.11477/mf.1416202730.

Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer's disease

Hu Y, Cho M, Sachdev P, Dage J, Hendrix S, Hansson O, Bateman RJ, Hampel H.

Med. 2024 Oct 11;5(10):1206-1226. doi: 10.1016/j.medj.2024.08.004. Epub 2024 Sep 9.

Association between blood-based protein biomarkers and brain MRI in the Alzheimer's disease continuum: a systematic review

Mitolo M, Lombardi G, Manca R, Nacmias B, Venneri A.

J Neurol. 2024 Nov;271(11):7120-7140. doi: 10.1007/s00415-024-12674-w. Epub 2024 Sep 12.

[Chinese guideline for clinical application of fluid biomarkers for Alzheimer's disease(2024 edition)]

National Health Commission Capacity Building and Continuing Education Center; Chinese Neuroscience Society; Aging Biomarker Consortium; Writing Group for the Chinese Guideline for Clinical Application of Fluid Biomarkers for Alzheimer′s Disease.

Zhonghua Yi Xue Za Zhi. 2024 Sep 10;104(35):3292-3306. doi: 10.3760/cma.j.cn112137-20240523-01174.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias